awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35025410-5045C3B5-A3F9-46AC-80FE-DA329FE28E2C
Q35025410-5045C3B5-A3F9-46AC-80FE-DA329FE28E2C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35025410-5045C3B5-A3F9-46AC-80FE-DA329FE28E2C
Kidney dysfunction during lenalidomide treatment for AL amyloidosis.
P2860
Q35025410-5045C3B5-A3F9-46AC-80FE-DA329FE28E2C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35025410-5045C3B5-A3F9-46AC-80FE-DA329FE28E2C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d5480e52fb4f7d251e377908c1ddb4c487d9c778
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.